Literature DB >> 23031144

Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort.

Mara A McAdams-DeMarco1, Janet W Maynard, Alan N Baer, Josef Coresh.   

Abstract

The authors quantified the impact of hypertension on gout incidence in middle-aged white and African American men and women. The Atherosclerosis Risk in Communities Study (ARIC) was a prospective population-based cohort that recruited patients between 1987 and 1989 from 4 US communities. Using a time-dependent Cox proportional hazards model, the authors estimated the adjusted hazard ratio (HR) of incident gout by time-varying hypertension and tested for mediation by serum urate level. There were 10,872 participants among whom 45% had hypertension during follow-up; 43% were men and 21% were African American. Over 9 years, 274 (2.5%) participants developed gout (1.8% of women and 3.5% of men). The unadjusted HR of incident gout was approximately 3 times (HR, 2.87; 95% confidence interval [CI], 2.24-3.78) greater for those with hypertension. Adjusting for confounders resulted in an attenuated but still significant association between hypertension and gout (HR, 2.00; 95% CI, 1.54-2.61). Adjustment for serum urate level further attenuated but did not abrogate the association (HR, 1.36, 95% CI, 1.04-1.79). There was no evidence of effect modification by sex (P=.35), race (P=.99), or obesity at baseline (P=.82). Hypertension was independently associated with increased gout risk in middle-aged African American and white adults. Serum urate level may be a partial intermediate on the pathway between hypertension and gout.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23031144      PMCID: PMC3464949          DOI: 10.1111/j.1751-7176.2012.00674.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  15 in total

Review 1.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

2.  Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout.

Authors:  A B GUTMAN; T F YU
Journal:  Am J Med       Date:  1957-10       Impact factor: 4.965

3.  Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Gary Curhan
Journal:  Arch Intern Med       Date:  2005-04-11

4.  Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004.

Authors:  Jeffrey A Cutler; Paul D Sorlie; Michael Wolz; Thomas Thom; Larry E Fields; Edward J Roccella
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

5.  Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study.

Authors:  J H Eckfeldt; L E Chambless; Y L Shen
Journal:  Arch Pathol Lab Med       Date:  1994-05       Impact factor: 5.534

Review 6.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors:  J Stamler; R Stamler; J D Neaton
Journal:  Arch Intern Med       Date:  1993-03-08

7.  Incidence and risk factors for gout in white men.

Authors:  R Roubenoff; M J Klag; L A Mead; K Y Liang; A J Seidler; M C Hochberg
Journal:  JAMA       Date:  1991-12-04       Impact factor: 56.272

8.  Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Authors:  Daniel I Feig; Beth Soletsky; Richard J Johnson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Racial differences in the incidence of gout. The role of hypertension.

Authors:  M C Hochberg; J Thomas; D J Thomas; L Mead; D M Levine; M J Klag
Journal:  Arthritis Rheum       Date:  1995-05
View more
  27 in total

Review 1.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

2.  Gout after living kidney donation: correlations with demographic traits and renal complications.

Authors:  Ngan N Lam; Amit X Garg; Dorry L Segev; Mark A Schnitzler; Huiling Xiao; David Axelrod; Daniel C Brennan; Bertram L Kasiske; Janet E Tuttle-Newhall; Krista L Lentine
Journal:  Am J Nephrol       Date:  2015-04-17       Impact factor: 3.754

3.  Gout in Older Adults: The Atherosclerosis Risk in Communities Study.

Authors:  Bridget Teevan Burke; Anna Köttgen; Andrew Law; Morgan Grams; Alan N Baer; Josef Coresh; Mara A McAdams-DeMarco
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-12-28       Impact factor: 6.053

4.  Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index.

Authors:  Richard J Reynolds; Ana I Vazquez; Vinodh Srinivasasainagendra; Yann C Klimentidis; S Louis Bridges; David B Allison; Jasvinder A Singh
Journal:  Rheumatol Int       Date:  2015-10-01       Impact factor: 2.631

5.  Physical Function, Hyperuricemia, and Gout in Older Adults.

Authors:  Bridget Teevan Burke; Anna Köttgen; Andrew Law; Beverly Gwen Windham; Dorry Segev; Alan N Baer; Josef Coresh; Mara A McAdams-DeMarco
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-12       Impact factor: 4.794

6.  Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.

Authors:  Lidan Ma; Ruixia Sun; Zhaotong Jia; Yaowu Zou; Ying Xin; Xiaoyu Cheng; Tian Liu; Lingling Cui; Zhen Liu; Xinjiang Wu; Changgui Li
Journal:  Clin Rheumatol       Date:  2018-01-22       Impact factor: 2.980

7.  A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea.

Authors:  Tingting Shi; Min Min; Chenyu Sun; Ce Cheng; Yun Zhang; Mingming Liang; Feras Kamel Rizeq; Yehuan Sun
Journal:  Sleep Breath       Date:  2019-03-22       Impact factor: 2.816

8.  Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study.

Authors:  Keiko I Greenberg; Mara A McAdams-DeMarco; Anna Köttgen; Lawrence J Appel; Josef Coresh; Morgan E Grams
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-25       Impact factor: 8.237

Review 9.  Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Teresa Norat; Lars J Vatten
Journal:  Eur J Nutr       Date:  2014-09-11       Impact factor: 5.614

Review 10.  Epidemiology of gout.

Authors:  Edward Roddy; Hyon K Choi
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.